3-[3-fluoro-4-[3-(4-piperidyl)propoxy]phenyl]-1-methyl-pyrazolo[3,4-d]pyrimidin-6-amine

ID: ALA4755173

PubChem CID: 129073113

Max Phase: Preclinical

Molecular Formula: C20H25FN6O

Molecular Weight: 384.46

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1nc(-c2ccc(OCCCC3CCNCC3)c(F)c2)c2cnc(N)nc21

Standard InChI:  InChI=1S/C20H25FN6O/c1-27-19-15(12-24-20(22)25-19)18(26-27)14-4-5-17(16(21)11-14)28-10-2-3-13-6-8-23-9-7-13/h4-5,11-13,23H,2-3,6-10H2,1H3,(H2,22,24,25)

Standard InChI Key:  YSLSSCOTQRLGCR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   28.9800  -18.1515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9788  -18.9752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6910  -19.3841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4048  -18.9747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4020  -18.1479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6892  -17.7385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1123  -17.7325    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.1173  -19.3822    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.8243  -18.9725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5368  -19.3800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2480  -18.9703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9605  -19.3777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9580  -20.1996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6664  -20.6111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3800  -20.2007    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3807  -19.3785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6678  -18.9666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2680  -17.7397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1824  -16.9229    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3789  -16.7532    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5174  -18.0764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9719  -17.4646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1708  -17.6338    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9142  -18.4142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4688  -19.0256    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2679  -18.8533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1110  -18.5853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0458  -16.0028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 18 19  2  0
 19 20  1  0
 20 22  1  0
 21 18  1  0
  1 18  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 24 27  1  0
 20 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4755173

    ---

Associated Targets(Human)

TLR7 Tclin Toll-like receptor 7 (2626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR8 Tchem Toll-like receptor 8 (1853 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR9 Tclin Toll-like receptor 9 (943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tlr7 Toll-like receptor 7 (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tlr9 Toll-like receptor 9 (360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.46Molecular Weight (Monoisotopic): 384.2074AlogP: 2.91#Rotatable Bonds: 6
Polar Surface Area: 90.88Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.36CX LogP: 2.65CX LogD: -0.13
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -1.14

References

1. Alper PB,Deane J,Betschart C,Buffet D,Collignon Zipfel G,Gordon P,Hampton J,Hawtin S,Ibanez M,Jiang T,Junt T,Knoepfel T,Liu B,Maginnis J,McKeever U,Michellys PY,Mutnick D,Nayak B,Niwa S,Richmond W,Rush JS,Syka P,Zhang Y,Zhu X.  (2020)  Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway.,  30  (17): [PMID:32738975] [10.1016/j.bmcl.2020.127366]

Source